Deficiency of ADAMTS13 plays a critical role in platelet accumulation in PA-ILI, suggesting that ADAMTS13 could be a potential therapeutic target for this condition.
TAK-755 is a recombinant version of the ADAMTS13 protein designed to replace the missing enzyme, which was given in the pivotal study as an intravenous infusion once every week or every other week.
医院供图 经过十余次线上线下多学科会诊，专家们一致认为，胎儿出生后可以通过注射“特效药”TAK-755来替代体内缺少的ADAMTS13酶，从而抑制血栓的 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback